SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Clinical Investigation

• Publication date

  2017-12-11

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1172/JCI95410PMID 29227283PMCID PMC5749505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A TGFβ-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression

  2016cited by this paper
• The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity

  2016cited by this paper
• MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis.

  2016cited by this paper
• MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells

  2016cited by this paper
• Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5

  2016cited by this paper
• A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation

  2016cited by this paper
• Histone H2A and H4 N-terminal Tails Are Positioned by the MEP50 WD Repeat Protein for Efficient Methylation by the PRMT5 Arginine Methyltransferase*

  2015cited by this paper
• The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond

  2015cited by this paper
• SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway

  2015cited by this paper
• A novel gammaretroviral shuttle vector insertional mutagenesis screen identifies SHARPIN as a breast cancer metastasis gene and prognostic biomarker

  2015cited by this paper
• Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3

  2015cited by this paper
• Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms.

  2014cited by this paper
• E3 ubiquitin ligase HOIP attenuates apoptotic cell death induced by cisplatin.

  2014cited by this paper
• Menin/PRMT5/hedgehog signaling: a potential target for the treatment of multiple endocrine neoplasia type 1 tumors.

  2013cited by this paper
• Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP

  2013cited by this paper
• Defining the RGG/RG motif.

  2013cited by this paper
• PRMT5 Is Upregulated in Malignant and Metastatic Melanoma and Regulates Expression of MITF and p27Kip1

  2013cited by this paper
• DNA methylation profile: a composer-, conductor-, and player-orchestrated Mammalian genome consisting of genes and transposable genetic elements.

  2012cited by this paper
• Crystal structure of the human PRMT5:MEP50 complex

  2012cited by this paper
• Expression of Microphthalmia-associated Transcription Factor (MITF), Which Is Critical for Melanoma Progression, Is Inhibited by Both Transcription Factor GLI2 and Transforming Growth Factor-β*

  2012cited by this paper
• Blue native polyacrylamide gel electrophoresis (BN-PAGE) for analysis of multiprotein complexes from cellular lysates.

  2011cited by this paper
• SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex

  2011cited by this paper
• SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis

  2011cited by this paper
• Transforming Growth Factor β‐Mediated Sox10 Suppression Controls Mesenchymal Progenitor Generation in Neural Crest Stem Cells

  2011cited by this paper
• RioK1, a New Interactor of Protein Arginine Methyltransferase 5 (PRMT5), Competes with pICln for Binding and Modulates PRMT5 Complex Composition and Substrate Specificity*

  2010cited by this paper
• Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells.

  2010influential reference
• A Role for ATF2 in Regulating MITF and Melanoma Development

  2010cited by this paper
• Comprehensive proteomic analysis of Schizosaccharomyces pombe by two-dimensional HPLC-tandem mass spectrometry.

  2009cited by this paper
• Ski co‐repressor complexes maintain the basal repressed state of the TGF‐β target gene, SMAD7, via HDAC3 and PRMT5

  2009cited by this paper
• Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation.

  2009cited by this paper
• Ski can negatively regulates macrophage differentiation through its interaction with PU.1

  2008cited by this paper
• Inhibition of PAX3 by TGF-beta modulates melanocyte viability.

  2008cited by this paper
• Arginine methylation regulates the p53 response

  2008cited by this paper
• Protein Arginine Methyltransferase 5 Suppresses the Transcription of the RB Family of Tumor Suppressors in Leukemia and Lymphoma Cells

  2008cited by this paper
• Nuclear and cytoplasmic c‐Ski differently modulate cellular functions

  2006cited by this paper
• Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.

  2006cited by this paper
• Human SWI/SNF-Associated PRMT5 Methylates Histone H3 Arginine 8 and Negatively Regulates Expression of ST7 and NM23 Tumor Suppressor Genes

  2004cited by this paper
• Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line.

  2002cited by this paper
• Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln.

  2001cited by this paper
• Regulation of chromatin structure by site-specific histone H3 methyltransferases

  2000cited by this paper
• The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling.

  1999cited by this paper
• Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor.

  1999cited by this paper

• Protein arginine methyltransferase 5 as a novel therapeutic target in solid tumors

  2025cites this paper
• Interplay of PRMTs and Identification of Biomarkers Through Machine Learning Algorithms in Pan‐Cancer, Highlighting PRMT3 as a Biomarker in Pancreatic Cancer

  2025cites this paper
• Methylation of KSHV vCyclin by PRMT5 contributes to cell cycle progression and cell proliferation

  2024cites this paper
• Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)

  2023cites this paper
• Mechanisms underlying linear ubiquitination and implications in tumorigenesis and drug discovery

  2023cites this paper
• The function of histone methylation and acetylation regulators in GBM pathophysiology

  2023cites this paper
• SHARPIN Enhances Ferroptosis in Synovial Sarcoma Cells via NF-κB- and PRMT5-Mediated PGC1α Reduction

  2023cites this paper
• PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer.

  2022cites this paper
• Molecular Insights in Uterine Leiomyosarcoma: A Systematic Review

  2022cites this paper
• SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling

  2022cites this paper
• Exploring Methods of Targeting Histone Methyltransferases and Their Applications in Cancer Therapeutics.

  2022cites this paper
• Arginine methyltransferase PRMT5 methylates and destabilizes Mxi1 to confer radioresistance in non-small cell lung cancer.

  2022cites this paper
• Protein arginine methyltransferases: promising targets for cancer therapy

  2021cites this paper
• SHARPIN: Role in Finding NEMO and in Amyloid-Beta Clearance and Degradation (ABCD) Pathway in Alzheimer’s Disease?

  2021cites this paper
• The Role of the PRMT5–SND1 Axis in Hepatocellular Carcinoma

  2021cites this paper
• Myelocytomatosis‐Protein Arginine N‐Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma

  2021cites this paper
• Identification of Somatic Genetic Alterations Using Whole-Exome Sequencing of Uterine Leiomyosarcoma Tumors

  2021cites this paper
• SHARPIN regulates the development of clear cell renal cell carcinoma by promoting von Hippel‐Lindau protein ubiquitination and degradation

  2021cites this paper
• Cellular pathways influenced by protein arginine methylation: Implications for cancer.

  2021cites this paper
• Targeting protein arginine methyltransferase 5 in cancers: Roles, inhibitors and mechanisms.

  2021cites this paper
• The parkin-coregulated gene product PACRG promotes TNF signaling by stabilizing LUBAC

  2020cites this paper
• PRMT5 function and targeting in cancer

  2020influential citation
• SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway.

  2020cites this paper
• Shank-associated RH domain interactor signaling in tumorigenesis

  2020influential citation
• PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity

  2020cites this paper
• The uncharacterized protein FAM47E interacts with PRMT5 and regulates its functions

  2020cites this paper
• Discovery of Novel PRMT5 Inhibitors by Virtual Screening and Biological Evaluations.

  2019cites this paper
• Post-translational modification of the death receptor complex as a potential therapeutic target in cancer

  2019cites this paper
• A novel role for SHARPIN in amyloid-β phagocytosis and inflammation by peripheral blood-derived macrophages in Alzheimer’s disease

  2019cites this paper
• Atypical ubiquitin-binding protein SHARPIN promotes breast cancer progression.

  2019cites this paper
• The regulation, functions and clinical relevance of arginine methylation

  2019cites this paper
• Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity

  2019cites this paper
• Integrin Binding Dynamics Modulate Ligand-Specific Mechanosensing in Mammary Gland Fibroblasts

  2019cites this paper
• Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors.

  2018cites this paper
• Inhibiting Arginine Methylation as a Tool to Investigate Cross-Talk with Methylation and Acetylation Post-Translational Modifications in a Glioblastoma Cell Line

  2018cites this paper
• Digital Commons

  year unknowncites this paper